TABLE 1.
Characteristic | No. (%) of investigations |
---|---|
Total CDC-assisted investigations (2006–2013) | 17 |
Sporadic cases | 4 (23.5) |
Clustera | 3 (17.6) |
Outbreak | 10 (58.8) |
Epi-Aid response | 3 (18) |
Associated with educational institution | 7 (41) |
Evidence of household transmissionb | 5 (29) |
Extrapulmonary involvementc | 2 (12) |
Macrolide resistance detectedc | 8 (47) |
Two to three cases with an epidemiological connection.
Not evaluated in all investigations.
Documented in at least one patient.